External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience WPC 2026
Roche and Genentech at

WPC 2026

May 24 - May 27
Phoenix, USA
wpc2026.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:30 AM
Duration 60mins Phoenix, USA
Prasinezumab in Early-Stage Parkinson's Disease: Additional Data from the PADOVA Study
Tania Nikolcheva
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 PM
Duration 120mins Phoenix, USA
ADVANCING INCLUSIVE REPRESENTATION IN EARLY-STAGE PARKINSON’S DISEASE CLINICAL TRIALS
Matthew May
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:30 AM
Duration 60mins Phoenix, USA
Topline results of a Phase Ib study testing an NLRP3 inflammasome inhibitor in early-stage Parkinson’s disease
Gennaro Pagano
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Phoenix, USA
Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial, 5-year update
Fabiana Gullotta
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Phoenix, USA
Prasinezumab's impact on neuromelanin- and iron-sensitive MRI biomarkers in Parkinson's disease: findings from the PADOVA phase IIB study
Thomas Kustermann
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 PM
Duration 120mins Phoenix, USA
Remote monitoring of motor signs in the PADOVA phase IIb study of prasinezumab: the role of the practically-defined OFF state
Werner Popp
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Phoenix, USA
Positive satisfaction with remote digital monitoring is related to monitoring adherence in the PADOVA study in people with early-stage PD
Werner Popp
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 PM
Duration 120mins Phoenix, USA
Partnering with people with Parkinson’s to shape the future of research and medicines development
Matthew May
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.